AI assistant
CONMED Corp — Director's Dealing 2013
Jun 4, 2013
31971_dirs_2013-06-04_680ab301-8821-4bca-84c6-74423439d9c4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2013-06-01
Reporting Person: JONAS DANIEL (VP Legal Affairs, Gen. Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-06-01 | Common Stock | M | 800 | — | Acquired | 4929 | Direct |
| 2013-06-01 | Common Stock | F | 290 | $32.93 | Disposed | 4639 | Direct |
| 2013-06-01 | Common Stock | M | 800 | — | Acquired | 5439 | Direct |
| 2013-06-01 | Common Stock | F | 290 | $32.93 | Disposed | 5149 | Direct |
| 2013-06-01 | Common Stock | M | 800 | — | Acquired | 5949 | Direct |
| 2013-06-01 | Common Stock | F | 290 | $32.93 | Disposed | 5659 | Direct |
| 2013-06-01 | Common Stock | M | 800 | — | Acquired | 6459 | Direct |
| 2013-06-01 | Common Stock | F | 290 | $32.93 | Disposed | 6169 | Direct |
| 2013-06-01 | Common Stock | M | 800 | — | Acquired | 6969 | Direct |
| 2013-06-01 | Common Stock | F | 290 | $32.93 | Disposed | 6679 | Direct |
| 2013-06-03 | Common Stock | M | 2000 | $16.46 | Acquired | 8679 | Direct |
| 2013-06-03 | Common Stock | F | 1358 | $33.20 | Disposed | 7321 | Direct |
| 2013-06-03 | Common Stock | M | 2000 | $19.26 | Acquired | 9321 | Direct |
| 2013-06-03 | Common Stock | F | 1466 | $33.20 | Disposed | 7855 | Direct |
| 2013-06-03 | Common Stock | M | 2000 | $27.63 | Acquired | 9855 | Direct |
| 2013-06-03 | Common Stock | F | 1787 | $33.20 | Disposed | 8068 | Direct |
| 2013-06-03 | Common Stock | M | 2000 | $26.09 | Acquired | 10068 | Direct |
| 2013-06-03 | Common Stock | F | 1728 | $33.20 | Disposed | 8340 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-06-01 | Rsus (restricted Stock Units) | $0 | M | 800 | Disposed | 2018-06-01 | Common Stock (800) | Direct |
| 2013-06-01 | Rsus (restricted Stock Units) | $0 | M | 800 | Disposed | 2019-06-01 | Common Stock (800) | Direct |
| 2013-06-01 | Rsus (restricted Stock Units) | $0 | M | 800 | Disposed | 2020-06-01 | Common Stock (800) | Direct |
| 2013-06-01 | Rsus (restricted Stock Units) | $0 | M | 800 | Disposed | 2021-06-01 | Common Stock (800) | Direct |
| 2013-06-01 | Rsus (restricted Stock Units) | $0 | M | 800 | Disposed | 2022-06-01 | Common Stock (800) | Direct |
| 2013-06-01 | Rsus (restricted Stock Units) | $0 | A | 4000 | Acquired | 2023-06-01 | Common Stock (4000) | Direct |
| 2013-06-01 | Sars (Stock Appreciation Rights) | $32.93 | A | 10000 | Acquired | 2023-06-01 | Common Stock (10000) | Direct |
| 2013-06-03 | Sars (Stock Appreciation Rights) | $16.46 | M | 2000 | Disposed | 2019-06-01 | Common Stock (2000) | Direct |
| 2013-06-03 | Sars (Stock Appreciation Rights) | $19.26 | M | 2000 | Disposed | 2020-06-01 | Common Stock (2000) | Direct |
| 2013-06-03 | Sars (Stock Appreciation Rights) | $27.63 | M | 2000 | Disposed | 2021-06-01 | Common Stock (2000) | Direct |
| 2013-06-03 | Sars (Stock Appreciation Rights) | $26.09 | M | 2000 | Disposed | 2022-06-01 | Common Stock (2000) | Direct |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per
share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2006 Stock
Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year
after the grant date.
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.
F3: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.